Can You Take Mounjaro With Amitriptyline?
 - Guide | Cured Pharmacy

Can You Take Mounjaro With Amitriptyline?

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

Featured Product

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00£124.99UK-based prescribers · Discreet delivery · Free private prescription
Start Assessment →✓ Lowest price guarantee
DISCOUNT CODE: FIRST20

£20 off for new patients

Tarun Kumar, Prescribing Pharmacist at Cured Pharmacy

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: 16 June 2026

Last Updated: 13 August 2026

If you are managing type 2 diabetes or obesity with Mounjaro and also taking amitriptyline for pain, depression, or sleep, it is completely understandable to feel uncertain about whether these two medicines are safe to use together. This is one of the most commonly searched questions by patients managing multiple conditions, and it deserves a clear, honest, evidence-based answer.

Quick Summary

Mounjaro (tirzepatide) and amitriptyline are both widely prescribed in the UK. While there is no severe direct pharmacokinetic interaction between them, taking both together raises some important clinical considerations around blood sugar control, weight management, and cardiovascular effects that every patient and prescriber should be aware of.

  • There is no absolute contraindication to using Mounjaro and amitriptyline together, but caution is advised.
  • Amitriptyline can promote weight gain and impair blood sugar regulation, potentially reducing Mounjaro's effectiveness.
  • Both medicines can affect heart rate, which warrants monitoring in vulnerable patients.
  • Mounjaro slows gastric emptying, which may alter how quickly amitriptyline is absorbed into the bloodstream.
  • Always inform your prescriber about all medicines you are taking before starting or changing either treatment.

Drug Interaction Checker: Mounjaro & Amitriptyline

Answer the questions below to understand your personal risk level when taking these two medicines together. This tool is for informational purposes only and does not replace professional medical advice.

1. What dose of amitriptyline are you currently taking?

2. Do you have type 2 diabetes?

3. Have you experienced any heart rhythm issues or palpitations?

Table of Contents

What is Mounjaro and How Does It Work?

Mounjaro is the brand name for tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It was originally approved for the treatment of type 2 diabetes and has since gained significant traction as a weight loss treatment across the UK. In 2026, it remains one of the most prescribed injectable medicines for people living with obesity or weight-related health conditions.

Mounjaro works by mimicking two naturally occurring hormones in the gut. It stimulates the pancreas to release insulin in a glucose-dependent manner, suppresses glucagon secretion, slows gastric emptying, and signals the brain to reduce appetite. These combined mechanisms result in meaningful improvements in blood sugar control and significant reductions in body weight for most people who use it.

It is administered as a weekly subcutaneous injection and comes in doses ranging from 2.5mg (the starting dose) up to 15mg. Because of its multi-hormone activity, tirzepatide tends to produce greater weight loss results compared to older GLP-1 receptor agonists. However, this also means it has a broader interaction profile that must be considered alongside other medicines.

  • Mounjaro is a dual GIP and GLP-1 receptor agonist given by weekly injection.
  • It improves blood sugar control and significantly reduces body weight.
  • It slows gastric emptying, which can affect the absorption of other oral medicines.
  • It is licensed in the UK for both type 2 diabetes and weight management.

What is Amitriptyline and Why is it Prescribed?

Amitriptyline is a tricyclic antidepressant (TCA) that has been available in the UK for decades. While it was originally developed to treat clinical depression, its use in modern UK practice has evolved significantly. Today, it is most commonly prescribed at low doses for neuropathic pain, fibromyalgia, chronic headaches, migraines, and insomnia. At higher doses, it is still used for depression, though SSRIs and SNRIs are now more commonly prescribed for that purpose.

The drug works by blocking the reuptake of serotonin and noradrenaline at nerve synapses, which alters pain signalling and mood regulation. It also has significant anticholinergic properties, meaning it blocks acetylcholine receptors, which contributes to side effects like dry mouth, constipation, urinary retention, and sedation. Its antihistamine activity also contributes to drowsiness and, critically for people using Mounjaro, to increased appetite and weight gain.

This weight-promoting effect of amitriptyline is a central concern for patients who are simultaneously trying to lose weight with Mounjaro. Understanding both drugs in depth is the foundation of answering the key question every patient needs to know: can you take Mounjaro with amitriptyline?

  • Amitriptyline is a tricyclic antidepressant used for pain, depression, migraines, and sleep.
  • It is commonly prescribed at low doses (10mg to 30mg) for neuropathic pain in the UK.
  • Its antihistamine and anticholinergic effects can cause significant weight gain.
  • It can affect heart rate and has a known impact on cardiac conduction.

Can You Take Mounjaro With Amitriptyline? Understanding the Interaction

This is the question that brings most people to this article, and the honest answer is nuanced. There is no absolute contraindication listed in Mounjaro's UK Summary of Product Characteristics (SmPC) specifically for amitriptyline. The two drugs do not share the same metabolic pathway in a way that causes a dangerous pharmacokinetic clash at a fundamental level. However, this does not mean that combining them is without risk, and it certainly does not mean they can be taken together without any form of medical oversight.

The concerns are primarily pharmacodynamic in nature, meaning they relate to how both drugs affect the body and how those effects may compound one another. The most significant areas of concern are blood sugar control, body weight, cardiac effects, and drug absorption. Each of these warrants its own discussion, but taken together they paint a picture of a combination that requires careful prescriber awareness and regular patient monitoring.

If you are currently on amitriptyline and your prescriber is considering adding Mounjaro for weight loss support, or vice versa, both parties need to have an honest and detailed conversation about your full medication list, current health status, and treatment goals. This is not a combination to manage alone.

  • There is no absolute contraindication to using both medicines together.
  • The primary concerns are indirect, relating to weight, blood sugar, and heart rate.
  • Medical supervision is strongly advised when both medicines are being used.
  • Low-dose amitriptyline (for pain or sleep) carries less metabolic risk than high-dose use.
  • Regular monitoring of blood glucose, heart rate, and body weight is advisable.

Specific Interaction Risks You Need to Know About

Even if two medicines do not interact dangerously at a biochemical level, they can still work against one another clinically. This is very much the case with Mounjaro and amitriptyline. Below are the key areas where these two drugs can conflict or compound each other's effects in ways that matter for your health.

Opposing Effects on Body Weight

One of the most tangible concerns is that amitriptyline is well known to cause weight gain, particularly at higher doses used for depression. This occurs through its antihistamine action on H1 receptors, which stimulates appetite, and its general sedating effect, which can reduce physical activity. Meanwhile, Mounjaro is prescribed precisely because it reduces appetite and promotes weight loss. These opposing effects can blunt the clinical benefit of Mounjaro, making it harder to achieve the weight loss targets that the treatment is designed to deliver.

Blood Sugar Regulation

Amitriptyline has been associated with impaired glucose tolerance and elevated blood sugar in several clinical studies. For patients using Mounjaro to manage type 2 diabetes, this counteractive effect can make glycaemic control more difficult to achieve and maintain. Your prescriber may need to monitor your HbA1c more frequently and adjust your Mounjaro dose accordingly.

Cardiac Conduction Effects

Amitriptyline is known to affect cardiac conduction, particularly QT interval prolongation, which relates to the electrical cycle of the heart. While tirzepatide does not itself cause significant QT prolongation, it can cause resting tachycardia (elevated heart rate) as a side effect. In patients with pre-existing cardiac conditions or in those taking higher doses of amitriptyline, the combined effect on the cardiovascular system may warrant an ECG and closer cardiac monitoring.

Sedation and Dizziness

Amitriptyline commonly causes sedation and postural hypotension (a drop in blood pressure when standing). Mounjaro, particularly in the early dose escalation phase, can also cause dizziness and light-headedness as part of its gastrointestinal side effect profile. These overlapping side effects may increase the risk of falls, particularly in older patients.

  • Amitriptyline can increase appetite and promote weight gain, counteracting Mounjaro's weight-reducing effects.
  • Tricyclic antidepressants can impair blood sugar regulation, working against Mounjaro's glycaemic benefits.
  • Both drugs can affect heart rate and blood pressure, requiring cardiovascular awareness.
  • Sedation and dizziness may be compounded when both medicines are taken together.
  • The clinical risk is most significant at higher amitriptyline doses above 75mg daily.

How Mounjaro's Effect on Gastric Emptying Affects Amitriptyline Absorption

One of the lesser-discussed but clinically relevant concerns about this combination relates to pharmacokinetics, specifically the way Mounjaro affects the speed at which the stomach empties its contents into the small intestine. Mounjaro significantly slows gastric emptying, and this is actually one of the mechanisms by which it reduces post-meal blood sugar spikes. However, this effect does not discriminate between food and oral medicines.

When gastric emptying is slowed, oral medicines like amitriptyline tablets may take longer to reach the small intestine, where most drug absorption occurs. This can delay the onset of amitriptyline's effect and, in some cases, alter the peak concentration of the drug in the bloodstream. While amitriptyline has a long half-life that reduces the clinical significance of minor absorption delays, this effect is worth bearing in mind, particularly if you notice that your amitriptyline seems less effective after starting Mounjaro.

The Mounjaro SmPC does acknowledge this gastric emptying effect and recommends that prescribers consider potential interactions with oral medicines where absorption timing is clinically important. If you take amitriptyline at a specific time for a specific reason, such as at night for sleep or at a set time for pain management, it is worth discussing timing strategies with your pharmacist.

  • Mounjaro slows gastric emptying, which can delay absorption of oral medicines including amitriptyline.
  • This may cause a delayed onset of effect rather than a dangerous drug interaction.
  • Patients should be aware that amitriptyline may feel less effective in the early weeks of Mounjaro treatment.
  • Your pharmacist can advise on optimal timing of both medicines.

How to Manage Both Medicines Safely

If your prescriber has decided that both Mounjaro and amitriptyline are clinically necessary for you, the next priority is managing them as safely and effectively as possible. This requires a proactive and collaborative approach between you and your healthcare team. The good news is that with appropriate monitoring and communication, most patients can use both medicines without experiencing serious problems.

First and foremost, ensure that every prescriber involved in your care is aware you are taking both medicines. In UK primary care, medication reviews are an important safeguard, but they only work if your prescriber has complete information. This is particularly relevant if your Mounjaro is prescribed through a private clinic or an online pharmacy, as your GP may not automatically have visibility of it on your medical record.

For patients using Mounjaro as part of a structured weight loss programme, it is worth discussing whether a lower dose of amitriptyline might achieve the same clinical goal with less metabolic interference. For example, if amitriptyline is being used for neuropathic pain, alternative analgesics with a more favourable metabolic profile, such as gabapentin or duloxetine, may be worth discussing with your GP.

Regular monitoring should include blood glucose or HbA1c checks, body weight tracking, blood pressure, and heart rate assessments. Patients who experience new or worsening palpitations, unexplained dizziness, or sudden changes in mood after starting either medicine should report these promptly to their prescriber.

  • Ensure all prescribers are fully informed about both medicines at all times.
  • Discuss whether alternative pain or depression treatments with fewer metabolic effects are appropriate.
  • Schedule regular monitoring appointments including blood glucose, weight, and blood pressure reviews.
  • Report any new symptoms such as palpitations, dizziness, or mood changes promptly.
  • Ask your pharmacist about the optimal timing for taking amitriptyline alongside Mounjaro.
  • Do not stop either medicine without first speaking to your prescriber.

Mounjaro vs Amitriptyline: Key Properties Compared

Property Mounjaro (Tirzepatide) Amitriptyline
Drug class Dual GIP/GLP-1 receptor agonist Tricyclic antidepressant (TCA)
Route of administration Weekly subcutaneous injection Oral tablet (daily)
Primary use Type 2 diabetes, weight management Depression, neuropathic pain, sleep, migraine prevention
Effect on body weight Significant weight loss Weight gain (especially at higher doses)
Effect on blood sugar Reduces blood glucose, improves HbA1c Can impair glucose tolerance
Cardiac effects May increase resting heart rate slightly QT prolongation risk, tachycardia at higher doses
Gastric emptying Significantly slows gastric emptying Anticholinergic effects also slow gut motility
Common side effects Nausea, vomiting, diarrhoea, injection site reactions Dry mouth, sedation, constipation, weight gain
Monitoring required Blood glucose, weight, renal function ECG in some patients, blood pressure, mental state
Drug interaction risk Moderate (via gastric emptying delay) Moderate to high (via metabolic and cardiac effects)

Key Takeaways

  • There is no absolute contraindication to taking Mounjaro and amitriptyline together, but the combination requires medical oversight and monitoring.
  • Amitriptyline can counteract Mounjaro's benefits by promoting weight gain and impairing blood sugar regulation, particularly at doses above 75mg.
  • Mounjaro's gastric emptying delay may slow the absorption of amitriptyline, potentially reducing its speed of effect without necessarily altering overall efficacy.
  • Both medicines can affect heart rate and blood pressure, making cardiovascular monitoring advisable, especially in older patients or those with pre-existing cardiac conditions.
  • Patients should ensure all prescribers and pharmacists are fully informed about every medicine they are taking, including any obtained through private or online prescribing services.

When to Seek Professional Advice

There are specific situations in which you should not wait for your next routine appointment but instead contact your GP, pharmacist, or prescribing service promptly. These include experiencing new or worsening palpitations or an irregular heartbeat after starting either medicine, unexplained episodes of dizziness or fainting particularly when standing up, sudden changes in mood, thoughts of self-harm, or a worsening of your mental health symptoms, blood sugar readings that are significantly outside your usual range, or a noticeable plateau or reversal in your weight loss progress after starting or increasing amitriptyline.

If you are currently prescribed amitriptyline and are considering Mounjaro for managing your weight in 2026, the safest first step is a structured medication review with your GP or prescribing pharmacist before starting treatment. This allows any potential concerns to be identified and managed proactively rather than reactively. Remember: do not stop taking either medicine without professional guidance, even if you are experiencing side effects.

Scientific References

  1. Electronic Medicines Compendium (eMC): Mounjaro (tirzepatide) Summary of Product Characteristics. Eli Lilly and Company Ltd. [Accessed 13 August 2026]
  2. British National Formulary (BNF): Amitriptyline hydrochloride. NICE/BNF. [Accessed 13 August 2026]
  3. NICE Guideline NG28: Type 2 diabetes in adults: management. National Institute for Health and Care Excellence. Updated 2022. [Accessed 13 August 2026]
  4. Mounjaro 2.5mg solution for injection in pre-filled pen (tirzepatide) Summary of Product Characteristics, Eli Lilly and Company Ltd, EMC, 2023 [Accessed 13 August 2026]
  5. Amitriptyline hydrochloride monograph, British National Formulary (BNF), NICE, 2024 [Accessed 13 August 2026]
  6. Type 2 diabetes in adults: management, NICE guideline NG28, National Institute for Health and Care Excellence, 2022 [Accessed 13 August 2026]
  7. Depression in adults: recognition and management, NICE guideline CG90, National Institute for Health and Care Excellence, 2022 [Accessed 13 August 2026]
  8. Tirzepatide (Mounjaro): summary of product safety, Drug Safety Update, Medicines and Healthcare products Regulatory Agency (MHRA), 2023 [Accessed 13 August 2026]
  9. Dahl D et al., Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial, Diabetes, Obesity and Metabolism, 2022 [Accessed 13 August 2026]

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today.

Once you complete a short online assessment, you will be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My AssessmentReturning Customer?Log In to Your Account

Frequently Asked Questions

How long does Mounjaro take to work when taken alongside amitriptyline?

Mounjaro typically begins reducing appetite within the first one to two weeks, with meaningful weight loss or blood sugar improvements seen after four to eight weeks. When taken alongside amitriptyline, progress may be slightly slower because amitriptyline can contribute to weight gain, but individual results will vary depending on dose and lifestyle.

Is it safe to take Mounjaro and amitriptyline at the same time?

Taking Mounjaro and amitriptyline at the same time is generally considered low risk in terms of direct pharmacological interaction, but it is not entirely without concern. Amitriptyline can cause weight gain and raise blood sugar, which works against Mounjaro's effects. Always consult your prescriber before combining these two medicines.

Can you take Mounjaro with amitriptyline if you have type 2 diabetes?

You can take Mounjaro with amitriptyline if you have type 2 diabetes, but you should do so only under medical supervision. Amitriptyline may impair blood sugar control, which could reduce the effectiveness of Mounjaro. Your prescriber may want to monitor your HbA1c and blood glucose more closely while you are on both medicines.

What is the dose of amitriptyline that causes the most concern when using Mounjaro?

Higher doses of amitriptyline, typically those above 75mg daily used for depression, are more likely to cause significant weight gain and blood sugar disruption, which may counteract Mounjaro's benefits. Lower doses of 10mg to 30mg, commonly used for pain or sleep, present a smaller metabolic risk but still warrant discussion with your prescriber.

Back to blog